Cleared Traditional

FERNO ILLE INFERNO MOIST HEAT THERAPY UT, 916/917 (K924023) - FDA 510(k) Clearance

Class I Physical Medicine device.

K924023 · Ferno · Physical Medicine device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1993
Decision
246d
Days
Class 1
Risk

K924023 is an FDA 510(k) clearance for the FERNO ILLE INFERNO MOIST HEAT THERAPY UT, 916/917. Classified as Unit, Heating, Powered (product code IRQ), Class I - General Controls.

Submitted by Ferno (Wilmington, US). The FDA issued a Cleared decision on April 14, 1993 after a review of 246 days - an extended review cycle.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5950 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.

View all Ferno devices

Submission Details

510(k) Number K924023 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 11, 1992
Decision Date April 14, 1993
Days to Decision 246 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
131d slower than avg
Panel avg: 115d · This submission: 246d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code IRQ Unit, Heating, Powered
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 890.5950
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.